Furthermore, Todaro et al. (71) showed that breast cancer stem-like cells (BCSC) isolated from patient tumors express the EPOR and respond to EPO treatment with increased proliferation and self-renewal. The gene discussed is EPOR; the disease is breast carcinoma.